Erythromycin inhibits neutrophilic inflammation and mucosal disease by upregulating DEL-1.
Maekawa T, Tamura H, Domon H, Hiyoshi T, Isono T, Yonezawa D, Hayashi N, Takahashi N, Tabeta K, Maeda T, Oda M, Ziogas A, Alexaki VI, Chavakis T, Terao Y, Hajishengallis G.
Maekawa T, et al. Among authors: isono t.
JCI Insight. 2020 Aug 6;5(15):e136706. doi: 10.1172/jci.insight.136706.
JCI Insight. 2020.
PMID: 32603314
Free PMC article.